Toggle menu
Toggle preferences menu
Toggle personal menu
Not logged in
Your IP address will be publicly visible if you make any edits.

Cassia cinnamon: Difference between revisions

From Pharmacopedia
[unchecked revision][unchecked revision]
home-claude publish gateway: wave-1 #3 (Cassia cinnamon / Cinnamomum cassia), full PlantMedTemplate buildout; herbalist-claude draft + home-claude resolved 4 citation gaps including Brancheau 2015 hepatotoxicity case report (PMID 25923145)
 
home-claude: binomial italics sweep (Mark rule 2026-05-26; body-prose only)
 
Line 2: Line 2:
| binomial            = Cinnamomum cassia (L.) J.Presl
| binomial            = Cinnamomum cassia (L.) J.Presl
| family              = Lauraceae
| family              = Lauraceae
| common_names        = Cassia cinnamon, Chinese cinnamon, cassia, gui (Chinese, the generic name), rou gui (Chinese, the bark), gui zhi (Chinese, the twig), dar-cini (Persian and Urdu, shared with Ceylon), qirfa (Arabic, shared with Ceylon); the synonymic binomial Cinnamomum aromaticum Nees appears in some older literature
| common_names        = Cassia cinnamon, Chinese cinnamon, cassia, gui (Chinese, the generic name), rou gui (Chinese, the bark), gui zhi (Chinese, the twig), dar-cini (Persian and Urdu, shared with Ceylon), qirfa (Arabic, shared with Ceylon); the synonymic binomial ''Cinnamomum'' aromaticum Nees appears in some older literature
| native_range        = southern China and northern Vietnam (Guangxi and Guangdong provinces are the principal historical and modern production areas); cultivated widely throughout southeast Asia, with related Cinnamomum loureirii (Saigon cinnamon, Vietnam) and Cinnamomum burmannii (Indonesian cinnamon, Java and Sumatra) frequently traded under the generic "cassia" or "cinnamon" name and supplying the majority of American grocery-store cinnamon
| native_range        = southern China and northern Vietnam (Guangxi and Guangdong provinces are the principal historical and modern production areas); cultivated widely throughout southeast Asia, with related ''Cinnamomum'' loureirii (Saigon cinnamon, Vietnam) and ''Cinnamomum'' burmannii (Indonesian cinnamon, Java and Sumatra) frequently traded under the generic "cassia" or "cinnamon" name and supplying the majority of American grocery-store cinnamon
| cultivars            = grade-based: Vietnamese cassia (C. loureirii, technically a distinct species) is often the highest-cinnamaldehyde and most pungent product; Chinese cassia (C. cassia proper) is the traditional TCM source; Indonesian cassia (C. burmannii, also a distinct species, also frequently sold as "cassia") is the lower-priced commodity cinnamon dominating American retail. The species distinctions matter for coumarin content (which varies among the three) and for cinnamaldehyde concentration, but the three are routinely sold interchangeably under the "cassia" or "cinnamon" name in the American market
| cultivars            = grade-based: Vietnamese cassia (C. loureirii, technically a distinct species) is often the highest-cinnamaldehyde and most pungent product; Chinese cassia (''C. cassia'' proper) is the traditional TCM source; Indonesian cassia (C. burmannii, also a distinct species, also frequently sold as "cassia") is the lower-priced commodity cinnamon dominating American retail. The species distinctions matter for coumarin content (which varies among the three) and for cinnamaldehyde concentration, but the three are routinely sold interchangeably under the "cassia" or "cinnamon" name in the American market
| parts_used          = inner bark (rou gui, the TCM and culinary form, the characteristic hollow tube quill); young twig (gui zhi, the TCM surface-resolving form); the leaf is less used than in C. verum; root bark, camphor-rich, used historically
| parts_used          = inner bark (rou gui, the TCM and culinary form, the characteristic hollow tube quill); young twig (gui zhi, the TCM surface-resolving form); the leaf is less used than in ''C. verum''; root bark, camphor-rich, used historically
| cultivation          = subtropical evergreen tree to 10 to 15 m at full size, maintained as coppice or semi-coppice for bark production; bark stripping is mechanically and chemically similar to the Ceylon practice but produces the characteristic single-layer thick rigid quill rather than the multi-layered brittle Ceylon scroll
| cultivation          = subtropical evergreen tree to 10 to 15 m at full size, maintained as coppice or semi-coppice for bark production; bark stripping is mechanically and chemically similar to the Ceylon practice but produces the characteristic single-layer thick rigid quill rather than the multi-layered brittle Ceylon scroll
| preparations_summary = bark powder 1 to 4 g daily for digestive carminative use (with the coumarin-content caveat below); bark essential oil 0.05 to 0.2 mL daily, diluted, never undiluted on skin or mucosa; rou gui (bark) 2 to 5 g per day in TCM decoction; gui zhi (twig) 3 to 10 g per day in TCM decoction; tincture 1:5 in 70 percent alcohol, 2 to 4 mL three times daily; aqueous extract for some glycemic-effect supplement formulations
| preparations_summary = bark powder 1 to 4 g daily for digestive carminative use (with the coumarin-content caveat below); bark essential oil 0.05 to 0.2 mL daily, diluted, never undiluted on skin or mucosa; rou gui (bark) 2 to 5 g per day in TCM decoction; gui zhi (twig) 3 to 10 g per day in TCM decoction; tincture 1:5 in 70 percent alcohol, 2 to 4 mL three times daily; aqueous extract for some glycemic-effect supplement formulations
Line 13: Line 13:
| legal                = unscheduled; GRAS for culinary use; widely sold worldwide as culinary spice and as dietary supplement; this is the cinnamon dominant in the American supermarket and the principal "cinnamon" of commercial baked goods
| legal                = unscheduled; GRAS for culinary use; widely sold worldwide as culinary spice and as dietary supplement; this is the cinnamon dominant in the American supermarket and the principal "cinnamon" of commercial baked goods
| interactionsummary  = modest hypoglycemic potentiation with insulin and oral antidiabetic medicines at therapeutic-dose supplementation (the trial evidence base is dominated by cassia); chronic high-intake coumarin hepatotoxicity is the principal clinically significant adverse-effect category for this species, distinguishing it from Ceylon and constraining the conservative chronic-supplementation dose; cinnamaldehyde contact dermatitis (common with concentrated essential oil and in spice-handling occupations); oral mucosal irritation possible at high concentrations; no clinically significant anticoagulant interaction (the cinnamon coumarin is not the 4-hydroxycoumarin warfarin class and lacks direct anticoagulant activity)
| interactionsummary  = modest hypoglycemic potentiation with insulin and oral antidiabetic medicines at therapeutic-dose supplementation (the trial evidence base is dominated by cassia); chronic high-intake coumarin hepatotoxicity is the principal clinically significant adverse-effect category for this species, distinguishing it from Ceylon and constraining the conservative chronic-supplementation dose; cinnamaldehyde contact dermatitis (common with concentrated essential oil and in spice-handling occupations); oral mucosal irritation possible at high concentrations; no clinically significant anticoagulant interaction (the cinnamon coumarin is not the 4-hydroxycoumarin warfarin class and lacks direct anticoagulant activity)
| intro                = '''Cassia cinnamon''' is the dried inner bark of Cinnamomum cassia (L.) J.Presl, a subtropical evergreen tree of the Lauraceae native to southern China and northern Vietnam and one of the foundational warming herbs of traditional Chinese medicine. The species is the cinnamon of the East Asian materia medica, the principal "cinnamon" of the American supermarket and of commercial baked goods, and the higher-coumarin twin of the Ceylon cinnamon ([[Ceylon cinnamon|Cinnamomum verum]]) with which it is routinely confused in commerce and clinical conversation. Cassia bark is documented in Chinese sources from the Han dynasty onward and appears in the foundational Chinese materia medica the Shennong Bencao Jing (compiled in the early centuries of the common era from older oral tradition) under the entry gui, which is the generic Chinese name for the cinnamon-family barks and twigs. The two principal TCM preparations of the bark are '''rou gui''' (the older, thick, ground-floor bark used as the chief warming-yang herb of the Chinese pharmacopoeia, indicated for kidney-yang deficiency, mingmen-fire weakness, and cold-pattern lumbar and abdominal pain) and '''gui zhi''' (the young twig used in surface-resolving formulas for early-stage external wind-cold patterns); the two are distinct in clinical use within TCM despite arising from the same plant. The cassia of Western commerce and clinical research is most often the bark, marketed under the generic "cinnamon" or "cassia" name without species discrimination from the related Cinnamomum loureirii (Saigon cinnamon, Vietnam) and Cinnamomum burmannii (Indonesian cinnamon, Java), both of which are botanically distinct species but commercially interchangeable with C. cassia in the modern global cinnamon supply. The principal safety distinction from Ceylon cinnamon is the coumarin content: cassia bark contains 0.4 to 4 percent coumarin by dry weight, against trace amounts in Ceylon, and chronic high dietary intake of cassia (heavy supplementation, large cinnamon-rich baked-goods consumption, or social-media "cinnamon challenge" levels) can exceed the European Food Safety Authority tolerable daily intake of 0.1 mg per kg body weight and produce hepatotoxicity in susceptible individuals.
| intro                = '''Cassia cinnamon''' is the dried inner bark of ''Cinnamomum cassia'' (L.) J.Presl, a subtropical evergreen tree of the Lauraceae native to southern China and northern Vietnam and one of the foundational warming herbs of traditional Chinese medicine. The species is the cinnamon of the East Asian materia medica, the principal "cinnamon" of the American supermarket and of commercial baked goods, and the higher-coumarin twin of the Ceylon cinnamon ([[Ceylon cinnamon|''Cinnamomum'' verum]]) with which it is routinely confused in commerce and clinical conversation. Cassia bark is documented in Chinese sources from the Han dynasty onward and appears in the foundational Chinese materia medica the Shennong Bencao Jing (compiled in the early centuries of the common era from older oral tradition) under the entry gui, which is the generic Chinese name for the cinnamon-family barks and twigs. The two principal TCM preparations of the bark are '''rou gui''' (the older, thick, ground-floor bark used as the chief warming-yang herb of the Chinese pharmacopoeia, indicated for kidney-yang deficiency, mingmen-fire weakness, and cold-pattern lumbar and abdominal pain) and '''gui zhi''' (the young twig used in surface-resolving formulas for early-stage external wind-cold patterns); the two are distinct in clinical use within TCM despite arising from the same plant. The cassia of Western commerce and clinical research is most often the bark, marketed under the generic "cinnamon" or "cassia" name without species discrimination from the related ''Cinnamomum'' loureirii (Saigon cinnamon, Vietnam) and ''Cinnamomum'' burmannii (Indonesian cinnamon, Java), both of which are botanically distinct species but commercially interchangeable with ''C. cassia'' in the modern global cinnamon supply. The principal safety distinction from Ceylon cinnamon is the coumarin content: cassia bark contains 0.4 to 4 percent coumarin by dry weight, against trace amounts in Ceylon, and chronic high dietary intake of cassia (heavy supplementation, large cinnamon-rich baked-goods consumption, or social-media "cinnamon challenge" levels) can exceed the European Food Safety Authority tolerable daily intake of 0.1 mg per kg body weight and produce hepatotoxicity in susceptible individuals.
| traditional_uses    = The Chinese tradition is the historical centroid of cassia cinnamon. The bark and twig are documented from the Han dynasty onward and appear in the foundational Chinese materia medica the Shennong Bencao Jing (compiled in the first or second century CE from older oral tradition) under the entry gui, classed in the upper grade of medicines (the rejuvenative tonics, used long-term without harm).<ref name="yang-shennong">Yang SZ (translator). ''The Divine Farmer's Materia Medica: A Translation of the Shen Nong Ben Cao Jing''. Boulder, CO: Blue Poppy Press; 1998.</ref> The clinical use of cassia in TCM was systematized by [[wikipedia:Zhang Zhongjing|Zhang Zhongjing]] in his Shang Han Lun ("Treatise on Cold Damage Disorders") of about 220 CE, the foundational Chinese clinical text on febrile and external-pathogen disease.<ref name="shanghan-lun">Mitchell C, Ye F, Wiseman N. ''Shang Han Lun: On Cold Damage, Translation and Commentaries''. Brookline, MA: Paradigm Publications; 1999.</ref> Zhang opened the Shang Han Lun with the formula '''Gui Zhi Tang''' (cassia twig, peony root, jujube, ginger, licorice), the foundational surface-resolving formula for early-stage external wind-cold disorder, and paired it with '''Ma Huang Tang''' (ephedra, cassia twig, almond, licorice) for the warming-and-dispersing pattern; the two formulas anchor the entire TCM tradition of treating cold-pattern external invasion and remain in routine modern use.
| traditional_uses    = The Chinese tradition is the historical centroid of cassia cinnamon. The bark and twig are documented from the Han dynasty onward and appear in the foundational Chinese materia medica the Shennong Bencao Jing (compiled in the first or second century CE from older oral tradition) under the entry gui, classed in the upper grade of medicines (the rejuvenative tonics, used long-term without harm).<ref name="yang-shennong">Yang SZ (translator). ''The Divine Farmer's Materia Medica: A Translation of the Shen Nong Ben Cao Jing''. Boulder, CO: Blue Poppy Press; 1998.</ref> The clinical use of cassia in TCM was systematized by [[wikipedia:Zhang Zhongjing|Zhang Zhongjing]] in his Shang Han Lun ("Treatise on Cold Damage Disorders") of about 220 CE, the foundational Chinese clinical text on febrile and external-pathogen disease.<ref name="shanghan-lun">Mitchell C, Ye F, Wiseman N. ''Shang Han Lun: On Cold Damage, Translation and Commentaries''. Brookline, MA: Paradigm Publications; 1999.</ref> Zhang opened the Shang Han Lun with the formula '''Gui Zhi Tang''' (cassia twig, peony root, jujube, ginger, licorice), the foundational surface-resolving formula for early-stage external wind-cold disorder, and paired it with '''Ma Huang Tang''' (ephedra, cassia twig, almond, licorice) for the warming-and-dispersing pattern; the two formulas anchor the entire TCM tradition of treating cold-pattern external invasion and remain in routine modern use.


Line 22: Line 22:
The Islamic and Persian medical traditions documented cassia within the same Dar-Cini and qirfa entries as Ceylon cinnamon, without (initially) distinguishing the two species; the practical Unani distinction between the higher-grade darchini-yi-suluqi (Sri Lankan, Ceylon) and inferior grades implicitly distinguished cassia as the cheaper and lower-grade product. The Avicennan indications (chronic cough, asthmatic complaints, dyspepsia, vomiting, weak constitution) apply to both species; cassia in the medieval Islamic pharmacopoeia was the cheaper and more available form for routine clinical use, while Ceylon was reserved for higher-grade prescription.
The Islamic and Persian medical traditions documented cassia within the same Dar-Cini and qirfa entries as Ceylon cinnamon, without (initially) distinguishing the two species; the practical Unani distinction between the higher-grade darchini-yi-suluqi (Sri Lankan, Ceylon) and inferior grades implicitly distinguished cassia as the cheaper and lower-grade product. The Avicennan indications (chronic cough, asthmatic complaints, dyspepsia, vomiting, weak constitution) apply to both species; cassia in the medieval Islamic pharmacopoeia was the cheaper and more available form for routine clinical use, while Ceylon was reserved for higher-grade prescription.


The European reception of cassia was the inverse of the Ceylon trade in scale and clinical prestige. Cassia was the cheaper alternative throughout the medieval and early modern European pharmacopoeial tradition; the Continental tradition (German, French, Dutch) more often accepted cassia where the British tradition preferred Ceylon. The American market, which developed in the nineteenth century outside the British colonial trade network for Ceylon, settled on cassia as the dominant cinnamon for both culinary and clinical use, and the modern American grocery-store "cinnamon" is overwhelmingly C. cassia or one of its related species (C. loureirii, C. burmannii) rather than C. verum.
The European reception of cassia was the inverse of the Ceylon trade in scale and clinical prestige. Cassia was the cheaper alternative throughout the medieval and early modern European pharmacopoeial tradition; the Continental tradition (German, French, Dutch) more often accepted cassia where the British tradition preferred Ceylon. The American market, which developed in the nineteenth century outside the British colonial trade network for Ceylon, settled on cassia as the dominant cinnamon for both culinary and clinical use, and the modern American grocery-store "cinnamon" is overwhelmingly ''C. cassia'' or one of its related species (C. loureirii, C. burmannii) rather than ''C. verum''.


The modern Western pharmacopoeial tradition recognizes cassia cinnamon (Cinnamomi cassiae cortex) separately from Ceylon, with the coumarin content as the principal safety distinction. The European Medicines Agency Committee on Herbal Medicinal Products issued a separate monograph for Cinnamomum cassia bark, with a specific coumarin-intake warning that the verum monograph does not carry.<ref name="ema-hmpc-cassia">European Medicines Agency, Committee on Herbal Medicinal Products. Community herbal monograph on ''Cinnamomum cassia'' Blume, cortex. EMA/HMPC/513617/2010 (the monograph documents are available from the EMA website).</ref> The German Federal Institute for Risk Assessment issued a 2012 statement on coumarin in cinnamon foods, noting that the EFSA tolerable daily intake of 0.1 mg coumarin per kg body weight is regularly exceeded by chronic high consumption of cassia-containing foods (heavy use of powdered cinnamon in oatmeal and baked goods, supplement use) and recommending Ceylon as the safer choice for chronic high-intake users.<ref name="bfr-coumarin">Bundesinstitut für Risikobewertung (German Federal Institute for Risk Assessment). ''Updated Health Assessment of Coumarin in Cinnamon and Other Foods''. BfR Opinion No 036/2006 (18 September 2006), with subsequent updates including the 2012 communication. Available from the BfR website.</ref> A small literature of case reports documents hepatotoxicity from chronic high-dose cassia supplementation in susceptible individuals, with onset typically over weeks to months of multi-gram daily intake and resolution on discontinuation; the reports are rare in absolute terms relative to the magnitude of cassia consumption worldwide, but the case-report literature is reproducible enough to constitute a real safety signal and is the empirical basis for the EMA and BfR coumarin warnings.<ref name="brancheau-2015">Brancheau D, Patel B, Zughaib M. Do cinnamon supplements cause acute hepatitis? ''The American Journal of Case Reports''. 2015 Apr 29;16:250-254. PMID 25923145.</ref>
The modern Western pharmacopoeial tradition recognizes cassia cinnamon (Cinnamomi cassiae cortex) separately from Ceylon, with the coumarin content as the principal safety distinction. The European Medicines Agency Committee on Herbal Medicinal Products issued a separate monograph for ''Cinnamomum cassia'' bark, with a specific coumarin-intake warning that the verum monograph does not carry.<ref name="ema-hmpc-cassia">European Medicines Agency, Committee on Herbal Medicinal Products. Community herbal monograph on ''Cinnamomum cassia'' Blume, cortex. EMA/HMPC/513617/2010 (the monograph documents are available from the EMA website).</ref> The German Federal Institute for Risk Assessment issued a 2012 statement on coumarin in cinnamon foods, noting that the EFSA tolerable daily intake of 0.1 mg coumarin per kg body weight is regularly exceeded by chronic high consumption of cassia-containing foods (heavy use of powdered cinnamon in oatmeal and baked goods, supplement use) and recommending Ceylon as the safer choice for chronic high-intake users.<ref name="bfr-coumarin">Bundesinstitut für Risikobewertung (German Federal Institute for Risk Assessment). ''Updated Health Assessment of Coumarin in Cinnamon and Other Foods''. BfR Opinion No 036/2006 (18 September 2006), with subsequent updates including the 2012 communication. Available from the BfR website.</ref> A small literature of case reports documents hepatotoxicity from chronic high-dose cassia supplementation in susceptible individuals, with onset typically over weeks to months of multi-gram daily intake and resolution on discontinuation; the reports are rare in absolute terms relative to the magnitude of cassia consumption worldwide, but the case-report literature is reproducible enough to constitute a real safety signal and is the empirical basis for the EMA and BfR coumarin warnings.<ref name="brancheau-2015">Brancheau D, Patel B, Zughaib M. Do cinnamon supplements cause acute hepatitis? ''The American Journal of Case Reports''. 2015 Apr 29;16:250-254. PMID 25923145.</ref>


The contemporary controlled-trial literature on cinnamon for type 2 diabetes is dominated by cassia rather than Ceylon, with most trial populations receiving Chinese or Indonesian cassia bark powder or extract. Meta-analyses have produced positive findings (modest reductions in fasting glucose), null findings, and intermediate findings; the most-cited recent meta-analysis (Allen 2013) reported modest improvements in fasting plasma glucose, total cholesterol, LDL, and triglycerides with cinnamon supplementation in patients with type 2 diabetes, with substantial between-study heterogeneity.<ref name="allen2013">Allen RW, Schwartzman E, Baker WL, Coleman CI, Phung OJ. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. ''Annals of Family Medicine''. 2013 Sep-Oct;11(5):452-459. PMID 24019277.</ref> Where observational and short-trial evidence has supported the glycemic-effect claim, larger and more recent randomized trials have tended toward modest or null effect; the role of cassia in type 2 diabetes management is a useful adjunctive at best, not a primary intervention, and the choice between cassia and Ceylon for chronic supplementation should weigh the modestly stronger cassia evidence against cassia's coumarin hepatotoxicity concern.
The contemporary controlled-trial literature on cinnamon for type 2 diabetes is dominated by cassia rather than Ceylon, with most trial populations receiving Chinese or Indonesian cassia bark powder or extract. Meta-analyses have produced positive findings (modest reductions in fasting glucose), null findings, and intermediate findings; the most-cited recent meta-analysis (Allen 2013) reported modest improvements in fasting plasma glucose, total cholesterol, LDL, and triglycerides with cinnamon supplementation in patients with type 2 diabetes, with substantial between-study heterogeneity.<ref name="allen2013">Allen RW, Schwartzman E, Baker WL, Coleman CI, Phung OJ. Cinnamon use in type 2 diabetes: an updated systematic review and meta-analysis. ''Annals of Family Medicine''. 2013 Sep-Oct;11(5):452-459. PMID 24019277.</ref> Where observational and short-trial evidence has supported the glycemic-effect claim, larger and more recent randomized trials have tended toward modest or null effect; the role of cassia in type 2 diabetes management is a useful adjunctive at best, not a primary intervention, and the choice between cassia and Ceylon for chronic supplementation should weigh the modestly stronger cassia evidence against cassia's coumarin hepatotoxicity concern.
| traditional_geography =
| traditional_geography =
| botany              = Cinnamomum cassia is a subtropical evergreen tree of the Lauraceae reaching 10 to 15 m at full size in undisturbed cultivation, maintained as coppice in commercial bark production. The leaves are opposite, oblong to elliptic, 10 to 18 cm long, with five (occasionally three) prominent palmate-pinnate veins running from the base to near the leaf apex; the five-vein pattern is one of the diagnostic distinctions from C. verum, which characteristically has three (occasionally five). The bark of mature trunks is grey-brown, deeply fissured; the medicinally used bark is the harder, thicker inner bark of coppice shoots, scraped of the outer corky layer and dried to form the characteristic single-layer thick rigid quill (a hollow tube rather than the multi-layered brittle scroll of Ceylon). The bark color is darker reddish-brown than the light tan of Ceylon. The flowers are small, greenish-yellow, in lax panicles; the fruit is a small drupe 1 to 2 cm long. The young twigs (gui zhi in TCM preparation) are slender, brown, and cinnamaldehyde-aromatic. Distinguished from Cinnamomum verum in whole-stick or whole-leaf material by the five-vs-three leaf venation, the single-layer-vs-multi-layer quill structure, the darker red-brown color, and the harder rigid texture; these distinctions hold for whole material and are lost in ground powder, where chemical or spectroscopic distinction (cinnamaldehyde-eugenol-coumarin ratio profiling) is required. Distinguished from Cinnamomum loureirii (Saigon cinnamon, the related Vietnamese species often sold interchangeably) by smaller leaf size and somewhat lower cinnamaldehyde content; from Cinnamomum burmannii (Indonesian cinnamon, the principal cassia of the American grocery supply) by leaf morphology and a different terpene profile.
| botany              = ''Cinnamomum cassia'' is a subtropical evergreen tree of the Lauraceae reaching 10 to 15 m at full size in undisturbed cultivation, maintained as coppice in commercial bark production. The leaves are opposite, oblong to elliptic, 10 to 18 cm long, with five (occasionally three) prominent palmate-pinnate veins running from the base to near the leaf apex; the five-vein pattern is one of the diagnostic distinctions from ''C. verum'', which characteristically has three (occasionally five). The bark of mature trunks is grey-brown, deeply fissured; the medicinally used bark is the harder, thicker inner bark of coppice shoots, scraped of the outer corky layer and dried to form the characteristic single-layer thick rigid quill (a hollow tube rather than the multi-layered brittle scroll of Ceylon). The bark color is darker reddish-brown than the light tan of Ceylon. The flowers are small, greenish-yellow, in lax panicles; the fruit is a small drupe 1 to 2 cm long. The young twigs (gui zhi in TCM preparation) are slender, brown, and cinnamaldehyde-aromatic. Distinguished from ''Cinnamomum verum'' in whole-stick or whole-leaf material by the five-vs-three leaf venation, the single-layer-vs-multi-layer quill structure, the darker red-brown color, and the harder rigid texture; these distinctions hold for whole material and are lost in ground powder, where chemical or spectroscopic distinction (cinnamaldehyde-eugenol-coumarin ratio profiling) is required. Distinguished from ''Cinnamomum'' loureirii (Saigon cinnamon, the related Vietnamese species often sold interchangeably) by smaller leaf size and somewhat lower cinnamaldehyde content; from ''Cinnamomum'' burmannii (Indonesian cinnamon, the principal cassia of the American grocery supply) by leaf morphology and a different terpene profile.
| constituents        = The principal medicinally active constituents of cassia bark are the volatile oil (1 to 2 percent of dry bark by weight, lower than Ceylon's 3 to 4 percent) and the proanthocyanidin polyphenol fraction. The volatile oil composition is the principal pharmacognostic distinction from Ceylon: cassia bark oil contains '''cinnamaldehyde''' at 75 to 90 percent of the oil (higher than Ceylon's 65 to 80 percent, accounting for cassia's more pungent and more one-note flavor), '''eugenol''' at less than 1 percent (against Ceylon's 5 to 10 percent), and '''coumarin''' at 0.4 to 4 percent of bark dry weight (against trace amounts in Ceylon, typically below 0.004 percent).<ref name="wang2013">Wang YH, Avula B, Nanayakkara NP, Zhao J, Khan IA. Cassia cinnamon as a source of coumarin in cinnamon-flavored food and food supplements in the United States. ''Journal of Agricultural and Food Chemistry''. 2013 May 8;61(18):4470-4476. PMID 23627682.</ref> The Wang 2013 quantitative analysis of US-market cinnamon samples established the cassia-coumarin levels at 7 to 12 mg per gram of cassia powder (the higher end of the range for Chinese cassia, the lower end for Indonesian cassia), against undetectable or sub-milligram-per-gram coumarin levels in Ceylon samples; the analytical distinction is the practical fingerprint by which the two species are separated in modern quality control and the empirical basis of the chronic-intake hepatotoxicity concern.
| constituents        = The principal medicinally active constituents of cassia bark are the volatile oil (1 to 2 percent of dry bark by weight, lower than Ceylon's 3 to 4 percent) and the proanthocyanidin polyphenol fraction. The volatile oil composition is the principal pharmacognostic distinction from Ceylon: cassia bark oil contains '''cinnamaldehyde''' at 75 to 90 percent of the oil (higher than Ceylon's 65 to 80 percent, accounting for cassia's more pungent and more one-note flavor), '''eugenol''' at less than 1 percent (against Ceylon's 5 to 10 percent), and '''coumarin''' at 0.4 to 4 percent of bark dry weight (against trace amounts in Ceylon, typically below 0.004 percent).<ref name="wang2013">Wang YH, Avula B, Nanayakkara NP, Zhao J, Khan IA. Cassia cinnamon as a source of coumarin in cinnamon-flavored food and food supplements in the United States. ''Journal of Agricultural and Food Chemistry''. 2013 May 8;61(18):4470-4476. PMID 23627682.</ref> The Wang 2013 quantitative analysis of US-market cinnamon samples established the cassia-coumarin levels at 7 to 12 mg per gram of cassia powder (the higher end of the range for Chinese cassia, the lower end for Indonesian cassia), against undetectable or sub-milligram-per-gram coumarin levels in Ceylon samples; the analytical distinction is the practical fingerprint by which the two species are separated in modern quality control and the empirical basis of the chronic-intake hepatotoxicity concern.


Cassia bark oil also contains smaller amounts of cinnamyl acetate, cinnamic acid, benzaldehyde, salicylaldehyde, and trace eugenol; the overall aromatic profile is sharper and more cinnamaldehyde-dominant than Ceylon's more complex sweet-warm bouquet.
Cassia bark oil also contains smaller amounts of cinnamyl acetate, cinnamic acid, benzaldehyde, salicylaldehyde, and trace eugenol; the overall aromatic profile is sharper and more cinnamaldehyde-dominant than Ceylon's more complex sweet-warm bouquet.


The non-volatile fraction includes '''proanthocyanidins''' (the type A doubly-linked oligomers characteristic of Cinnamomum, contributing to antioxidant and astringent activity), '''MHCP''' (methylhydroxychalcone polymer, identified at higher concentrations in cassia than in Ceylon and proposed as the principal insulin-mimetic constituent), and a range of cinnamic acid derivatives.
The non-volatile fraction includes '''proanthocyanidins''' (the type A doubly-linked oligomers characteristic of ''Cinnamomum'', contributing to antioxidant and astringent activity), '''MHCP''' (methylhydroxychalcone polymer, identified at higher concentrations in cassia than in Ceylon and proposed as the principal insulin-mimetic constituent), and a range of cinnamic acid derivatives.
| preparations        = The traditional Chinese forms are the '''rou gui''' (the bark, used in TCM decoction at 2 to 5 g per day, with the highest grades reserved for specific tonic formulations) and '''gui zhi''' (the twig, used in TCM decoction at 3 to 10 g per day, with Gui Zhi Tang the foundational Shang Han Lun formula). The Western therapeutic forms are the '''bark powder''' (1 to 4 g daily, with the coumarin-content caveat constraining the upper limit in chronic high-intake users); the '''bark essential oil''' (steam-distilled, 0.05 to 0.2 mL daily, diluted; never undiluted on skin or mucosa, and never as a primary medicinal route in chronic use because of the concentrated coumarin and cinnamaldehyde irritation); the '''tincture''' (1:5 in 70 percent alcohol, 2 to 4 mL three times daily); and the '''aqueous extract''' (used in some glycemic-effect supplement formulations to concentrate the polyphenol and MHCP fraction while reducing the essential-oil and coumarin content).
| preparations        = The traditional Chinese forms are the '''rou gui''' (the bark, used in TCM decoction at 2 to 5 g per day, with the highest grades reserved for specific tonic formulations) and '''gui zhi''' (the twig, used in TCM decoction at 3 to 10 g per day, with Gui Zhi Tang the foundational Shang Han Lun formula). The Western therapeutic forms are the '''bark powder''' (1 to 4 g daily, with the coumarin-content caveat constraining the upper limit in chronic high-intake users); the '''bark essential oil''' (steam-distilled, 0.05 to 0.2 mL daily, diluted; never undiluted on skin or mucosa, and never as a primary medicinal route in chronic use because of the concentrated coumarin and cinnamaldehyde irritation); the '''tincture''' (1:5 in 70 percent alcohol, 2 to 4 mL three times daily); and the '''aqueous extract''' (used in some glycemic-effect supplement formulations to concentrate the polyphenol and MHCP fraction while reducing the essential-oil and coumarin content).
| indications          = Carminative and digestive aid for postprandial bloating, mild dyspepsia, and flatulence (the principal Commission E indication). Type 2 diabetes mellitus glycemic adjunct (the principal modern clinical indication, with most trial evidence from cassia rather than Ceylon; modest effect; not a primary intervention). TCM-specific indications: kidney-yang deficiency syndrome (rou gui), mingmen-fire weakness with cold abdominal pain or chronic diarrhea (rou gui), cold-pattern dysmenorrhea and amenorrhea (rou gui), early-stage external wind-cold disorder with chills and absent sweating (gui zhi in Gui Zhi Tang and Ma Huang Tang), warming-the-meridians for cold-pattern arthritis and musculoskeletal complaint (gui zhi). Mild antimicrobial and antifungal traditional use. Folk indications: warming for cold-pattern complaint, dysmenorrhea, and as a flavoring synergist in compound formulations.
| indications          = Carminative and digestive aid for postprandial bloating, mild dyspepsia, and flatulence (the principal Commission E indication). Type 2 diabetes mellitus glycemic adjunct (the principal modern clinical indication, with most trial evidence from cassia rather than Ceylon; modest effect; not a primary intervention). TCM-specific indications: kidney-yang deficiency syndrome (rou gui), mingmen-fire weakness with cold abdominal pain or chronic diarrhea (rou gui), cold-pattern dysmenorrhea and amenorrhea (rou gui), early-stage external wind-cold disorder with chills and absent sweating (gui zhi in Gui Zhi Tang and Ma Huang Tang), warming-the-meridians for cold-pattern arthritis and musculoskeletal complaint (gui zhi). Mild antimicrobial and antifungal traditional use. Folk indications: warming for cold-pattern complaint, dysmenorrhea, and as a flavoring synergist in compound formulations.
Line 53: Line 53:
| pregnancy_details    = Culinary amounts of cassia cinnamon are considered safe in pregnancy and lactation, with a long historical record of routine use in essentially all cinnamon-using cultures. Therapeutic-dose supplementation (multi-gram daily for glycemic effect, or essential oil for any indication) and the cassia-coumarin chronic-intake concern apply in pregnancy as in the general population, with the additional consideration that fetal coumarin exposure has not been formally studied at the relevant intake levels; the conservative recommendation is to limit pregnant patients to culinary doses of cassia (or to substitute Ceylon at any chronic supplementation level) and to avoid concentrated cassia essential oil entirely in pregnancy.
| pregnancy_details    = Culinary amounts of cassia cinnamon are considered safe in pregnancy and lactation, with a long historical record of routine use in essentially all cinnamon-using cultures. Therapeutic-dose supplementation (multi-gram daily for glycemic effect, or essential oil for any indication) and the cassia-coumarin chronic-intake concern apply in pregnancy as in the general population, with the additional consideration that fetal coumarin exposure has not been formally studied at the relevant intake levels; the conservative recommendation is to limit pregnant patients to culinary doses of cassia (or to substitute Ceylon at any chronic supplementation level) and to avoid concentrated cassia essential oil entirely in pregnancy.
| monitoring          = For patients on insulin or oral antidiabetic medicines who add cassia supplementation at therapeutic dose, fasting glucose monitoring at baseline and at two to four weeks of regular supplementation is the conservative practice. For chronic high-intake cassia consumers (multi-gram daily cassia powder supplementation for indefinite duration, or comparable heavy dietary intake), liver function test monitoring at baseline and periodically (every six to twelve months) is reasonable, particularly in patients with pre-existing hepatic disease or concurrent hepatotoxic medicine use; substitution of Ceylon for cassia in chronic high-intake users is the preferable alternative to ongoing LFT surveillance.
| monitoring          = For patients on insulin or oral antidiabetic medicines who add cassia supplementation at therapeutic dose, fasting glucose monitoring at baseline and at two to four weeks of regular supplementation is the conservative practice. For chronic high-intake cassia consumers (multi-gram daily cassia powder supplementation for indefinite duration, or comparable heavy dietary intake), liver function test monitoring at baseline and periodically (every six to twelve months) is reasonable, particularly in patients with pre-existing hepatic disease or concurrent hepatotoxic medicine use; substitution of Ceylon for cassia in chronic high-intake users is the preferable alternative to ongoing LFT surveillance.
| counseling          = The most important counseling distinction for cinnamon is the species, and patients seeking cinnamon for chronic high-intake therapeutic use should generally choose Ceylon ([[Ceylon cinnamon]]) rather than cassia because of the coumarin-content difference. The cinnamon sold as a culinary spice in most American grocery stores and used in commercial baked goods is C. cassia or one of its related species (C. loureirii Saigon cinnamon, C. burmannii Indonesian cinnamon), not C. verum Ceylon cinnamon. The visual distinction between cassia and Ceylon is possible with whole sticks but lost in ground powder. Cassia is darker reddish-brown, composed of a single thick rigid layer rolled into a hollow tube, hard and resistant to crushing, with a strong, simple, pungent aroma; Ceylon is light tan, composed of many thin papery layers tightly rolled into a multi-quill scroll, brittle and easily crushed, with a delicate, complex, sweet aroma.
| counseling          = The most important counseling distinction for cinnamon is the species, and patients seeking cinnamon for chronic high-intake therapeutic use should generally choose Ceylon ([[Ceylon cinnamon]]) rather than cassia because of the coumarin-content difference. The cinnamon sold as a culinary spice in most American grocery stores and used in commercial baked goods is ''C. cassia'' or one of its related species (C. loureirii Saigon cinnamon, C. burmannii Indonesian cinnamon), not ''C. verum'' Ceylon cinnamon. The visual distinction between cassia and Ceylon is possible with whole sticks but lost in ground powder. Cassia is darker reddish-brown, composed of a single thick rigid layer rolled into a hollow tube, hard and resistant to crushing, with a strong, simple, pungent aroma; Ceylon is light tan, composed of many thin papery layers tightly rolled into a multi-quill scroll, brittle and easily crushed, with a delicate, complex, sweet aroma.


For patients consuming cinnamon at routine culinary levels (gram or fraction of gram per day, sprinkled on food), the coumarin exposure from cassia is unlikely to reach the tolerable daily intake threshold and species choice is not a clinical priority. For patients consuming cinnamon at therapeutic supplementation levels (multi-gram daily, particularly the powdered form in capsules) or at high dietary levels (large quantities in baked goods, daily heavy-cinnamon oatmeal, social-media "cinnamon challenge" of swallowed dry powder), the coumarin exposure from cassia can substantially exceed safe daily intake. The Ceylon species is the appropriate substitution for chronic high-intake users; cassia is the appropriate choice for short-course supplementation (weeks to a few months) and for routine culinary use where chronic exposure is moderate.
For patients consuming cinnamon at routine culinary levels (gram or fraction of gram per day, sprinkled on food), the coumarin exposure from cassia is unlikely to reach the tolerable daily intake threshold and species choice is not a clinical priority. For patients consuming cinnamon at therapeutic supplementation levels (multi-gram daily, particularly the powdered form in capsules) or at high dietary levels (large quantities in baked goods, daily heavy-cinnamon oatmeal, social-media "cinnamon challenge" of swallowed dry powder), the coumarin exposure from cassia can substantially exceed safe daily intake. The Ceylon species is the appropriate substitution for chronic high-intake users; cassia is the appropriate choice for short-course supplementation (weeks to a few months) and for routine culinary use where chronic exposure is moderate.
Line 59: Line 59:
The social-media "cinnamon challenge" (swallowing a tablespoon of dry cinnamon powder) carries the acute risks of aspiration and aspiration pneumonia (dry cinnamon powder is highly aspirable and reaches the lower airways) and the cumulative-coumarin risk only with repeated practice; the acute aspiration danger is the more immediate concern. Cinnamon essential oil (either species) is concentrated and irritating; it should never be applied undiluted to skin or mucosa, and oral consumption of essential oil at more than a few drops daily can produce gastritis, oral mucositis, and (with chronic high-dose cassia oil specifically) hepatotoxicity. Cinnamon chewing-gum stomatitis is a recognized presentation of intra-oral mucosal hypersensitivity to high-concentration cinnamaldehyde, more common with cassia than Ceylon because of cassia's higher cinnamaldehyde content; presentations generally resolve on cessation. Contact dermatitis from cinnamon (especially the essential oil and especially cassia) is a regular occupational concern in spice-handling industries and culinary work.
The social-media "cinnamon challenge" (swallowing a tablespoon of dry cinnamon powder) carries the acute risks of aspiration and aspiration pneumonia (dry cinnamon powder is highly aspirable and reaches the lower airways) and the cumulative-coumarin risk only with repeated practice; the acute aspiration danger is the more immediate concern. Cinnamon essential oil (either species) is concentrated and irritating; it should never be applied undiluted to skin or mucosa, and oral consumption of essential oil at more than a few drops daily can produce gastritis, oral mucositis, and (with chronic high-dose cassia oil specifically) hepatotoxicity. Cinnamon chewing-gum stomatitis is a recognized presentation of intra-oral mucosal hypersensitivity to high-concentration cinnamaldehyde, more common with cassia than Ceylon because of cassia's higher cinnamaldehyde content; presentations generally resolve on cessation. Contact dermatitis from cinnamon (especially the essential oil and especially cassia) is a regular occupational concern in spice-handling industries and culinary work.
| anecdotes            =
| anecdotes            =
| seealso              = [[Ceylon cinnamon]], [[Cinnamomum verum]], [[Ginger]], [[Turmeric]], [[Cardamom]], [[Cloves]], [[Star anise]], [[Garlic]]
| seealso              = [[Ceylon cinnamon]], ''[[Cinnamomum verum]]'', [[Ginger]], [[Turmeric]], [[Cardamom]], [[Cloves]], [[Star anise]], [[Garlic]]
| references          = <references/>
| references          = <references/>
}}
}}